Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.
Kwang Ho In(Brigham and Women's Hospital), Jeffrey M. Drazen(Harvard University Press), S W Kim(Harvard University Press), Chandri Yandava(Broad Institute), K Serino(NKT Therapeutics (United States)), David R. Beier(Seattle Children's Hospital), William W. Busse(UW Health University Hospital), Elliot Israel(Brigham and Women's Hospital), Eric S. Silverman(Brigham and Women's Hospital), Tucker Collins(Harvard University), J Grobholz(Harvard University Press), Ji Murray(Brigham and Women's Hospital), D Tinkleman(Abbott (United Kingdom)), Anthony Pillari(Harvard University Press), Paul Rubin(Abbott (United Kingdom)), George T. De Sanctis(Harvard University Press), D Ledford(Abbott (United Kingdom)), James P. Kemp(Abbott (United Kingdom)), Tim P. Keith(Software (Germany)), Patricia W. Finn(Harvard University Press), Kazuhito Asano(Harvard University Press), Andrew R. Fischer(Harvard University Press), Edward Silverman(Brigham and Women's Hospital), Anthony W. Segal(University College London)
Cited by 336
Related Papers
Structure, function and diversity of the healthy human microbiome
|Nature|2012|11.9k
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
|Journal of Allergy and Clinical Immunology|2001|1.3k
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
|New England Journal of Medicine|2011|870